Clinical Trials Browser

Triple Negative Breast Neoplasms × Immunotherapy, Active × Breast × Clear all

NCT06324240 2026-01-26

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Phase 1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms